Annual Operating Margin
-21.40 K%
+5037.49%+19.05%
31 December 2022
Summary:
Navidea Biopharmaceuticals annual operating profit margin is currently -21.40 thousand%, with the most recent change of +5037.49% (+19.05%) on 31 December 2022. During the last 3 years, it has fallen by -12.38 thousand% (-137.23%). NAVB annual operating margin is now -126365.96% below its all-time high of 16.95%, reached on 31 December 2000.NAVB Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
N/A
30 September 2023
Summary:
Navidea Biopharmaceuticals quarterly operating profit margin is not available.NAVB Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB Operating Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -137.2% | - |
| 5 y5 years | -536.3% | - |
NAVB Operating Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -137.2% | +19.1% | ||
| 5 y | 5 years | -536.3% | +48.0% | ||
| alltime | all time | <-9999.0% | +48.0% |
Navidea Biopharmaceuticals Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -21.40 K%(-19.1%) | -524.30 K%(+696.0%) |
| Sept 2022 | - | -65.87 K%(+46.9%) |
| June 2022 | - | -44.83 K%(-88.3%) |
| Dec 2021 | -26.44 K%(+193.1%) | -383.08 K%(+1342.0%) |
| Sept 2021 | - | -26.57 K%(+30.0%) |
| June 2021 | - | -20.44 K%(+38.0%) |
| Mar 2021 | - | -14.81 K%(+364.3%) |
| Dec 2020 | -9021.84%(-78.1%) | -3189.32%(-92.5%) |
| Sept 2020 | - | -42.80 K%(+63.1%) |
| June 2020 | - | -26.24 K%(+49.5%) |
| Mar 2020 | - | -17.55 K%(-83.0%) |
| Dec 2019 | -41.18 K%(+1124.5%) | -103.44 K%(+64.2%) |
| Sept 2019 | - | -63.01 K%(+274.7%) |
| June 2019 | - | -16.81 K%(-78.2%) |
| Mar 2019 | - | -77.26 K%(+1129.6%) |
| Dec 2018 | -3363.29%(-73.6%) | -6283.11%(-62.3%) |
| Sept 2018 | - | -16.68 K%(+1717.9%) |
| June 2018 | - | -917.41%(-99.7%) |
| Mar 2018 | - | -314.36 K%(+715.1%) |
| Dec 2017 | -12.72 K%(+6129.6%) | -38.57 K%(+699.6%) |
| June 2017 | - | -4823.86%(-1692.2%) |
| Dec 2016 | -204.13%(-66.6%) | 302.97%(-707.5%) |
| Sept 2016 | - | -49.87%(-74.0%) |
| June 2016 | - | -191.98%(-51.6%) |
| Mar 2016 | - | -396.25%(-1341.4%) |
| Dec 2015 | -611.97%(+39.0%) | 31.92%(-129.4%) |
| Sept 2015 | - | -108.64%(-18.2%) |
| June 2015 | - | -132.87%(-64.2%) |
| Mar 2015 | - | -370.70%(+82.1%) |
| Dec 2014 | -440.38%(-87.0%) | -203.61%(-14.6%) |
| Sept 2014 | - | -238.33%(-72.2%) |
| June 2014 | - | -857.51%(-24.9%) |
| Mar 2014 | - | -1141.13%(-53.2%) |
| Dec 2013 | -3399.73%(-90.4%) | -2439.90%(-1.6%) |
| Sept 2013 | - | -2478.85%(-42.8%) |
| June 2013 | - | -4330.48%(-95.8%) |
| Dec 2012 | -35.55 K%(+781.5%) | -103.23 K%(+1049.7%) |
| June 2012 | - | -8978.25%(-83.5%) |
| Mar 2012 | - | -54.53 K%(+2053.6%) |
| Dec 2011 | -4032.67%(+96.4%) | - |
| Sept 2011 | - | -2532.20%(-95.7%) |
| June 2011 | - | -58.47 K%(+3827.8%) |
| Mar 2011 | - | -1488.66%(+125.8%) |
| Dec 2010 | -2053.28%(>+9900.0%) | -659.38%(-72.7%) |
| Sept 2010 | - | -2419.03%(+6513.0%) |
| June 2010 | - | -36.58%(-43.5%) |
| Mar 2010 | - | -64.70%(+276.4%) |
| Dec 2009 | -19.17%(-42.0%) | -17.19%(+37.3%) |
| Sept 2009 | - | -12.52%(-74.3%) |
| June 2009 | - | -48.63%(+541.6%) |
| Mar 2009 | - | -7.58%(-39.9%) |
| Dec 2008 | -33.04%(-93.7%) | -12.62%(-85.0%) |
| Sept 2008 | - | -84.22%(+318.2%) |
| June 2008 | - | -20.14%(+13.5%) |
| Mar 2008 | - | -17.74%(-99.1%) |
| Dec 2007 | -523.42% | -1905.37%(>+9900.0%) |
| Sept 2007 | - | -4.54%(-90.3%) |
| June 2007 | - | -46.66%(+17.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2007 | - | -39.73%(-19.4%) |
| Dec 2006 | -57.19%(-7.1%) | -49.32%(-64.7%) |
| Sept 2006 | - | -139.73%(+255.8%) |
| June 2006 | - | -39.27%(+10.4%) |
| Mar 2006 | - | -35.57%(-49.8%) |
| Dec 2005 | -61.56%(+83.3%) | -70.84%(-5.0%) |
| Sept 2005 | - | -74.56%(+18.2%) |
| June 2005 | - | -63.06%(+61.6%) |
| Mar 2005 | - | -39.02%(-44.2%) |
| Dec 2004 | -33.58%(+35.7%) | -69.98%(+497.6%) |
| Sept 2004 | - | -11.71%(-55.6%) |
| June 2004 | - | -26.40%(-26.4%) |
| Mar 2004 | - | -35.85%(+31.4%) |
| Dec 2003 | -24.75%(-59.7%) | -27.28%(-43.8%) |
| Sept 2003 | - | -48.56%(+1923.3%) |
| June 2003 | - | -2.40%(-92.2%) |
| Mar 2003 | - | -30.73%(+162.9%) |
| Dec 2002 | -61.40%(-1044.6%) | -11.69%(-90.2%) |
| Sept 2002 | - | -118.93%(+70.3%) |
| June 2002 | - | -69.85%(-12.6%) |
| Mar 2002 | - | -79.96%(-850.1%) |
| Dec 2001 | 6.50%(-61.7%) | 10.66%(+53.4%) |
| Sept 2001 | - | 6.95%(+7.9%) |
| June 2001 | - | 6.44%(+290.3%) |
| Mar 2001 | - | 1.65%(-93.4%) |
| Dec 2000 | 16.95%(-134.9%) | 24.89%(+33.2%) |
| Sept 2000 | - | 18.68%(-10.4%) |
| June 2000 | - | 20.85%(-802.0%) |
| Mar 2000 | - | -2.97%(-94.9%) |
| Dec 1999 | -48.50%(-90.1%) | - |
| June 1999 | - | -57.89%(-21.4%) |
| Mar 1999 | - | -73.68%(-87.5%) |
| Dec 1998 | -488.08%(-8.2%) | -588.79%(+163.4%) |
| Sept 1998 | - | -223.53%(-36.8%) |
| June 1998 | - | -353.85%(-56.4%) |
| Mar 1998 | - | -811.11%(+56.0%) |
| Dec 1997 | -531.69%(-72.7%) | -519.96%(+20.7%) |
| Sept 1997 | - | -430.77%(-38.5%) |
| June 1997 | - | -700.00%(+42.6%) |
| Mar 1997 | - | -490.91%(-61.7%) |
| Dec 1996 | -1950.00%(+71.1%) | -1283.33%(-62.8%) |
| Sept 1996 | - | -3450.00%(+27.8%) |
| June 1996 | - | -2700.00%(+35.0%) |
| Mar 1996 | - | -2000.00%(+81.8%) |
| Dec 1995 | -1140.00%(-13.1%) | -1100.00%(-62.1%) |
| Sept 1995 | - | -2900.00%(+222.2%) |
| June 1995 | - | -900.00%(-6.9%) |
| Mar 1995 | - | -966.67%(-3.3%) |
| Dec 1994 | -1311.11%(-84.0%) | -1000.00%(-31.0%) |
| Sept 1994 | - | -1450.00%(+38.1%) |
| June 1994 | - | -1050.00%(-59.6%) |
| Mar 1994 | - | -2600.00%(+18.2%) |
| Dec 1993 | -8200.00%(+173.3%) | - |
| Sept 1993 | - | -2200.00%(+10.0%) |
| June 1993 | - | -2000.00%(+53.8%) |
| Mar 1993 | - | -1300.00%(+62.5%) |
| Dec 1992 | -3000.00% | - |
| Sept 1992 | - | -800.00% |
FAQ
- What is Navidea Biopharmaceuticals annual operating profit margin?
- What is the all time high annual operating margin for Navidea Biopharmaceuticals?
- What is the all time high quarterly operating margin for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual operating profit margin?
The current annual operating margin of NAVB is -21.40 K%
What is the all time high annual operating margin for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual operating profit margin is 16.95%
What is the all time high quarterly operating margin for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly operating profit margin is 302.97%